132 related articles for article (PubMed ID: 14585254)
21. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation.
Lam CT; Lau CP; Leung SK; Tse HF; Lee KL; Tang MO; Tsang V
Europace; 2000 Oct; 2(4):286-91. PubMed ID: 11194594
[TBL] [Abstract][Full Text] [Related]
22. Near elimination of ventricular pacing in SafeR mode compared to DDD modes: a randomized study of 422 patients.
Davy JM; Hoffmann E; Frey A; Jocham K; Rossi S; Dupuis JM; Frabetti L; Ducloux P; Prades E; Jauvert G
Pacing Clin Electrophysiol; 2012 Apr; 35(4):392-402. PubMed ID: 22309303
[TBL] [Abstract][Full Text] [Related]
23. Late follow-up of dual-chamber rate-adaptive pacing.
Benditt DG; Wilbert L; Hansen R; Alagona P; Greenawald K; Ghali MG; Wheelan K; Steinhaus D; Collins J; Fetter J
Am J Cardiol; 1993 Mar; 71(8):714-9. PubMed ID: 8447271
[TBL] [Abstract][Full Text] [Related]
24. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
[TBL] [Abstract][Full Text] [Related]
25. Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up.
Russo V; Nigro G; Rago A; Antonio Papa A; Proietti R; Della Cioppa N; Cristiano A; Palladino A; Calabrò R; Politano L
Acta Myol; 2013 Dec; 32(3):142-7. PubMed ID: 24803841
[TBL] [Abstract][Full Text] [Related]
26. The use of implantable sensors for the control of pacemaker mediated tachycardias: a comparative evaluation between minute ventilation sensing and acceleration sensing dual chamber rate adaptive pacemakers.
Lau CP; Tai YT; Fong PC; Li JP; Chung FL; Song S
Pacing Clin Electrophysiol; 1992 Jan; 15(1):34-44. PubMed ID: 1370998
[TBL] [Abstract][Full Text] [Related]
27. Is dual defibrillator better than conventional DDD pacing in brady-tachy syndrome? Results of the ICARUS Trial (Internal Cardioversion Antitachypacing and Prevention: Resource Utilization Study).
Santini M; Ricci R; Pignalberi C; Russo M; Magris B; Grovale N; De Santo T
J Interv Card Electrophysiol; 2005 Dec; 14(3):159-68. PubMed ID: 16421692
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of closed-loop stimulation with epicardial leads in an infant with congenital atrioventricular block.
Di Pino A; Agati S; Bianca I
Europace; 2008 Mar; 10(3):334-5. PubMed ID: 18204100
[TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy changes following pacemaker implantation in patients with bradycardia-tachycardia syndrome.
Rucinski P; Rubaj A; Kutarski A
Expert Opin Pharmacother; 2006 Nov; 7(16):2203-13. PubMed ID: 17059377
[TBL] [Abstract][Full Text] [Related]
30. AAIsafeR limits ventricular pacing in unselected patients.
Pioger G; Leny G; Nitzsché R; Ripart A
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S66-70. PubMed ID: 17302721
[TBL] [Abstract][Full Text] [Related]
31. Improved cardiac function and quality of life following upgrade to dual chamber pacing after long-term ventricular stimulation.
Höijer CJ; Brandt J; Willenheimer R; Juul-Möller S; Boström PA
Eur Heart J; 2002 Mar; 23(6):490-7. PubMed ID: 11863352
[TBL] [Abstract][Full Text] [Related]
32. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
[TBL] [Abstract][Full Text] [Related]
33. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm.
Pürerfellner H; Ruiter JH; Widdershoven JW; Van Gelder IC; Urban L; Kirchhof CJ; Havlicek A; Kornet L;
Heart Rhythm; 2006 Oct; 3(10):1164-71. PubMed ID: 17018345
[TBL] [Abstract][Full Text] [Related]
34. Brady-tachy syndrome: rapid atrial pacing efficacy in preventing atrial fibrillation recurrence assessed by reliable electrograms: the prefib pilot study.
Flammang D; Loteanu V; Hamani D; Lambiez M; Flammang-Dorie G
Europace; 2005 Sep; 7(5):482-9. PubMed ID: 16087114
[TBL] [Abstract][Full Text] [Related]
35. Optimizing pacemaker longevity with pacing mode and settings programming: results from a pacemaker multicenter registry.
Benkemoun H; Sacrez J; Lagrange P; Amiel A; Prakash A; Himmrich E; Aimè E; Mairesse GH; Guénon C; Sbragia P
Pacing Clin Electrophysiol; 2012 Apr; 35(4):403-8. PubMed ID: 22309354
[TBL] [Abstract][Full Text] [Related]
36. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome.
Nielsen JC; Thomsen PE; Højberg S; Møller M; Vesterlund T; Dalsgaard D; Mortensen LS; Nielsen T; Asklund M; Friis EV; Christensen PD; Simonsen EH; Eriksen UH; Jensen GV; Svendsen JH; Toff WD; Healey JS; Andersen HR;
Eur Heart J; 2011 Mar; 32(6):686-96. PubMed ID: 21300730
[TBL] [Abstract][Full Text] [Related]
37. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing.
Nielsen JC; Thomsen PE; Højberg S; Møller M; Riahi S; Dalsgaard D; Mortensen LS; Nielsen T; Asklund M; Friis EV; Christensen PD; Simonsen EH; Eriksen UH; Jensen GV; Svendsen JH; Toff WD; Healey JS; Andersen HR;
Europace; 2012 May; 14(5):682-9. PubMed ID: 22106360
[TBL] [Abstract][Full Text] [Related]
38. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
[TBL] [Abstract][Full Text] [Related]
39. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms.
Blanc JJ; De Roy L; Mansourati J; Poezevara Y; Marcon JL; Schoels W; Hidden-Lucet F; Barnay C;
Europace; 2004 Sep; 6(5):371-9. PubMed ID: 15294260
[TBL] [Abstract][Full Text] [Related]
40. Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up.
Gillis AM; Morck M; Exner DV; Sheldon RS; Duff HJ; Mitchell BL; Wyse GD
Europace; 2009 Aug; 11(8):1041-7. PubMed ID: 19460849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
